INTRODUCTION
Laminin is a multidomain glycoprotein localized mainly in basement membranes. As isolated from the Englebreth-Holm-Swarm (EHS) tumor and many other tissues, laminin is composed of three polypeptide chains, referred to as Bl (M, 222,000), B2 (M, 210,000) , and A (M, 4,000,OOO). The chains are held together by disulfide bonds to form a cross-shaped molecule (Timpl et al., 1979) . The complete amino acid sequences of all three chains of EHS laminin have been recently published (Sasaki et al., 198'7; Sasaki et a,Z., 1988) . Laminin has diverse effects on a variety of cells, including stimulation of adhesion, migration, growth, and differentiation (Martin and Timpl, 1987; Kleinman et al., 1987a) . Studies with proteolytic fragments, domain-specific antibodies, and synthetic peptides have identified different regions of laminin with biological activity. Two of the major cell binding regions are localized at the cross intersection (Terranova et ah, 1983; Skubitz et al., 1987; Graf et al., 1987; Charonis et al., 1988; Kleinman et al., 1989) and at the terminal end of the long arm (Aumailley ef aZ., 1987; Goodman et al, 1987; Tashiro et a,Z., 1989) .
Laminin is already present in early preimplantation embryos (Cooper and MaeQueen, 1983) and thereafter is largely restricted to basement membranes of a variety of tissues during all stages of development (Wu et al., 1983) . Recent studies of kidney organogenesis have shown that the different laminin chains are not coordinately expressed during embryogenesis, suggesting that molecular isoforms might also exist (Ekblom et al, 1990; Kleinman et al., 1987b; Laurie et al, 1989) . Relying, in part, on the existence of these spatial and temporal distributions of the molecule and their coincidence with key developmental events, laminin has been postulated to be instrumental for organ development (Ekblom et al, 1980 (Ekblom et al, , 1986 (Ekblom et al, , 1990 Martin and Timpl, 1987) .
In a recent study, we established that laminin plays an important role in the morphogenesis of embryonic mouse lung. Using polyclonal antibodies to laminin, we demonstrated that the antibodies were able to penetrate lung tissue in organ culture, localize at the basement membrane, and interfere with branch formation. Antibodies to two other components of the extracellular matrix, thrombospondin and entactin, failed to alter the normal pattern of development (Schuger et al., 1990; unpublished) . These findings are extended in the current DEVELOPMENTAL BIOLOGY VOLUME 146. 1991 1. Diagrammatic models of the monoclonal antibody binding sites on laminin Anti-laminin monoclonal antibodies AL-l, Al-Z, Al-3, AL-4, and AL-5 were incubated with laminin and analyzed by electron microscopy after rotary shadowing. (Skubitz et al, 1987 .
investigation using a series of monoclonal antibodies to distinct domains of laminin. We demonstrate that the inhibition observed is the result of interference with functions that can be localized to specific regions of the laminin molecule.
MATERIALS AND METHODS
Isolation and culture of embryonic lungs. CD-l strain (Charles River) mice were mated and the day a vaginal plug was found designated as Day 0. Pregnant females were sacrificed by cervical dislocation on Day 12 of gestation. Uteri were removed to sterile phosphate-buffered saline (PBS), and the lungs were dissected from the embryos with watchmakers forceps using a dissecting microscope. The lower right lobe was further dissected and cultured at the air-medium interface on the upper surface of polycarbonate filter membrane assemblies, 0.4-pm pore size, (Millipore, Bedford, MA). The culture medium used was minimal essential medium, (GIBCO, Grand Island, NY) containing 10% fetal calf serum (Hyclone Lab, Logan, UT), nonessential amino acids (GIBCO), 0.29 mg/ml L-glutamine (Irvine Scientific, Santa Ana, CA), 100 U/ml penicillin, 100 pg/ml streptomycin, and 0.25 pg/ml amphotericin B (Irvine Scientific). Cultures were incubated at 37°C in 5% CO, and fed daily by a complete change of medium.
Lung explants maintained in organ culture continue to develop in vitro. The transparency of the tissue, plus the transparency of the polycarbonate filter in which the organ buds are grown, allows continuous monitoring of epithelial branching morphogenesis. By Day 12 of gestation (at the time that the lungs are dissected), the right lower lobe presents four to six terminal buds. After 3 days in culture there is a lo-fold or greater increase in the number of terminal buds.
Anti-laminin mono&ma1 antibodies. Five monoclonal antibodies (AL-l to AL-5) were generated against laminin by immunization of male LOU/MNCr rats. The preparation, purification, and characterization of these antibodies have been previously described (Skubitz et al., 1987 . All of the antibodies were of the IgG class except AL-5, which was an IgM; each antibody reacted with laminin by solid phase radioimmunoassay and radioimmunoprecipitation (Skubitz et al., 1987 . The regions on laminin to which each antibody bound ( Fig. 1) were determined by Western immunoblotting in combination with electron microscopy (Skubitz et al., 1987 . Normal rat IgG and normal rat IgM were purchased from Cappel (Malvern, PA).
Conjugation of antibody with jkn-ochrome. For some studies, selected monoclonal antibodies were conjugated with fluorescein isothiocyanate (FITC) according to the technique described by Goding, (1976) . Briefly, 2 mg/ml of antibody in 0.1 M sodium carbonate buffer, pH 9.0, was incubated with 50 yl of FITC (Molecular Probes, Eugene, OR) dissolved in DMSO at 1 mg/ml. This mixture was incubated at 4°C in the dark for 8 hr. Then NH, Cl was added at a final concentration of 50 mM and the mixture reaction was incubated at 4°C for another 2 hr. The reaction was stopped with xylene cyan01 and glycerol at a final concentration of 0.1 and 5%) respectively. The free FITC was separated from the FITC-antibody conjugates on a 25-ml G-50-80 column (Sigma) equilibrated in 1 X PBS. Optical densities per each antibody were taken (FITC at 495 nm and protein at 280 nm) and the fluorochrome:protein ratio was calculated. All the ratios fell into the optimal range (0.3 to 1.0).
Culture of lung explants in the presence of monoclonal antibodies to laminin and control immunoglobulins.
Right lower lobes dissected from embryonic lungs at Day 12 of gestation were cultured for 3 days in the presence of various purified monoclonal antibodies or control normal rat immunoglobulins from the classes G (IgG) and M (IgM). The antibodies, as well as the control IgG and IgM, were added to the wells in 100 cl1 of PBS at a final concentration of 50 or 100 pg/ml. The culture medium was replaced daily and antibody or control immunoglobulin replenished. For additional control experiments, the explants were left untreated. The experiments were repeated six times, providing a total of 12 explants for each antibody or control at 100 pg/ml and 8 explants for each antibody and control at 50 pg/ml. In two additional experiments, anti-laminin antibodies at Lamir~in i n Lung Denelopmen t 533 a concentration of 100 yg/ml were preadsorbed with 100 pg of laminin for 1 h prior to being introduced into the medium. As previously reported (Schuger et ab, 1990) , branching morphogenesis was monitored and photographed using a phase-contrast microscope and the number of terminal branches was recorded daily. At the end of each experiment, the percentage of branching inhibition per explant was calculated as Immunohistoch,emistry. Lungs removed from Day 12 embryos were immediately frozen in OCT embedding compound (Miles, Naperville, IL). Blocks were stored at -70°C prior to sectioning. Ten-micrometer sections were cut and collected on polylysine-coated slides. Sections were air dried and exposed in a moist chamber to 400 U/ml bovine testes hyaluronidase (Cappel) for 20 min. Sections were then exposed to 5% normal goat serum followed by the primary antibody for 2 hr at room temperature.
Monoclonal antibodies AL-l, AL-2, A-3, and AL-4 (all IgG's) and normal rat IgG were used at a dilution of 1:lO; monoclonal antibody AL-5 (an IgM) and normal rat IgM were used at a dilution of 1:50. The sections were then washed in PBS and exposed to a 150 dilution of the secondary antibody (FITC-conjugated goat anti-rat IgG or IgM; Cappel) for 30 min at room temperature.
Sections were washed extensively in PBS and coverslipped with glycerol containing 0.1% phenylenediamine (Sigma, St. Louis, MO). As an additional control, sections were also treated with just PBS containing no primary immunoglobulin.
In further studies, tissue sections were consecutively exposed to two different monoclonal antibodies. For these experiments the second antibody was FITC-conjugated.
The purpose of these studies was to determine possible sharing of tissue binding sites by different antibodies. If this is indeed the case, then it could be expected that incubation of a tissue section with the proper antibody will block further binding of a second, FITC-conjugated antibody. In contrast, if the two antibodies do not share common tissue binding sites then the positive stain observed with an FITC-conjugated antibody should not be abolished by previous exposure of the section to the first antibody.
To determine penetration and immunolocalization of the various monoclonal antibodies in the explants, tissues were incubated with the appropriate monoclonal antibody or with control immunoglobulin for 24 hr. Samples were then frozen in situ by filling the membrane assembly with OCT at -20°C. The samples were then processed for immunohistochemistry as above except that the primary antibody was omitted during the immunostaining procedure. Light microscopy. Lung explants unexposed or exposed to the different antibodies were examined under light microscopy. For morphological detail and assessment of tissue preservation after culture, lung explants were fixed in 10% phosphate-buffered formalin, rinsed with PBS, and dehydrated through graded alcohols to 100%. The samples were embedded in glycolmethacrylate (Polysciences, Warrington, PA). Five-micrometer sections were cut, mounted on slides, and stained with hematoxylin-eosin.
Mitotic activity was determined on frozen sections from lung explants exposed for 48 hr to the various monoclonal antibodies (100 yg/ml). Control explants were left unexposed or exposed to IgG. Total number of mitotic figures in the mesenchymal and epithelial compartments was determined by screening 16 fields (magnification 80) per explant.
RESULTS
Immunolocalixation studies. All five of the monoclonal antibodies were immunoreactive with the embryonic lung tissue. AL-l, which in Western immunoblots recognizes the A chain and binds to the cross region of laminin (Fig. l) , stained the epithelial basement membrane and, to a minor degree, the extracellular matrix compartment ( Fig. 2A) . AL-2, which recognizes A and B chains and binds to the long arm of the molecule near the cross region, presented a very similar pattern of reactivity (Fig. 2B ). AL-3 and AL-4, which recognize B and A chains, respectively, and bind, the former to the inner rod segment of the B chain(s) and the latter to the carboxy1 end of the A chain, stained only the epithelial basement membrane (Figs. 2C and 2D ). Al-5, which binds to the globular segments of the lateral short arms (B chains), reacted weakly with the epithelial basement membrane and presented a pattern of diffuse staining throughout the extracellular matrix (Fig. 2E) . None of the antibodies recognized vascular basement membranes. The data are summarized in Table 1 .
Eflects of monoclonal anti-lam&in antibodies on lung branching morphogenesis. We next examined the effects of the monoclonal antibodies on lung morphogenesis. Branch formation was measured as described under Materials and Methods. Consistent with our previous report (Schuger et ah, 1990) bryonic mouse lung underwent active branch formation were observed in explants cultured in the presence of over the subsequent 3-day period. The mean number of 100 pg/ml of normal rat IgG (Fig. 3A) or normal rat IgM terminal buds by the third day in control cultures was 53 or in the presence of an equal concentration of AL-2, (SD = '7; range 49-80). Similar numbers of branches AL-3 (Fig. 3C) , or AL-4. In contrast, AL-l and AL-5 significantly decreased the number of terminal buds (Figs. 3E and 3G, respectively) .
Qualitative differences in the pattern of branching of the affected explants were observed with both antibodies.
Their branching configuration was irregular and accompanied by segmental dilatation (Figs. 3E and 3G) . Inhibition was concentration-dependent over the range 50-100 pg/ml. The decrease in the number of branches was evident after 1 day in culture. By the second day in culture, at which time antibody effect was maximal, the percentage of branching inhibition was greater than 30% for antibody concentration of 100 pg/ml (Fig. 4) and 18% for antibody concentration of 50 pg/ml (not shown). Significant inhibition was still observed after 3 days but there was more variability among the different explants in the same treatment groups. The inhibition observed with DEVELOPMENTAL BIOLOGY VOLUME 146,1991 AL-l and AL-5 was statistically significant at both concentrations used (50 and 100 pg/ml) after 1 and 2 days. After 3 days, statistical significance was observed only at the highest concentration.
The effects of both AL-l and AL-5 were abrogated by preadsorption with 100 pg of laminin for 60 min prior to use.
Immunojuorescence localization of the antibodies in the lung explants after antibody treatment. Immunohistochemistry was used to assess the efficiency of the antibodies added to the organ cultures to penetrate the explants. For these experiments, lung explants were cultured for 2 days in the presence of monoclonal antibodies and control IgG or IgM as described under Materials and Methods. At the end of the treatment period, frozen sections obtained from the treated and control explants were exposed directly to an FITC-conjugated goat Fab fragment of anti-rat IgG or anti-rat IgM. These experiments showed that all of the monoclonal antibodies effectively penetrated the lung tissue during the course of the experiments and reacted with the appropriate tissue epitopes. The patterns of reactivity seen in the organ cultures were very similar to those observed originally when the antibodies were used for conventional immunohistochemistry on fresh, uncultured lungs. Antibodies AL-l, AL-2, AL-3, and AL-4 reacted primarily with the basement membrane while AL-5 was reactive with groups of cells in close proximity to the airway lumen (Figs. 3D, 3F, 3H ). However, AL-l and AL-2 immunoreactivity was not diffusely present in the extracellular matrix as was observed in the immunolocalization studies done on fresh, uncultured lungs.
At the end of the incubation period, lung explants were examined histologically for tissue viability. A complete preservation of tissue architecture was observed in all cases. Mitotic figures and occasional single necrotic cells were seen in both treated and control explants (Fig. 5) . Thus, there were no cytological abnormalities associated with inhibition of branch formation.
Eflects of mono&ma1 anti-lam&in antibodies on mitotic activity. Lung explants were cultured for 2 days in the presence of monoclonal antibodies AL-l or AL-5 or in the presence of IgG as described under Materials and Methods. At the end of this period the number of mitotic figures was determined on frozen sections obtained from three explants exposed to AL-l, three explants exposed to AL-5, two exposed to IgG, and one unexposed. Both AL-l and AL-5 significantly decreased the number of mitotic figures in the epithelium compared to unexposed lungs or lungs exposed to control IgG. (In one experiment the epithelium of lung explants exposed to AL-l and AL-5 presented 45 and 40 mitotic figures/explant, respectively, compared to 73 in IgG exposed explant.) However, we did not see a decrease in mitotic figures in the mesenchymal compartment of the AL-land AL-5-treated explants. In fact, there was actually an increase in the number of mesenchymal mitotic figures in these explants. In the experiment presented above, the mesenchyme of lungs exposed to AL-1 and AL-5 showed 43 and 40 mitotic figures/explant, respectively, compared to 22 in IgG exposed explant. The experiments were repeated in three instances with similar results. The significance of this is not known at present.
Immunohistochemical studies with a combination of unlabeled and FITC-labeled mono&ma1 antibodies. Immunohistochemistry was used to determine whether the positive stain obtained with FITC-conjugated antibodies AL-l and AL-5 could be blocked by preincubation of the tissue sections with unconjugated AL-l or AL-5. In these studies preincubation of the tissue sections with unconjugated AL-l did not inhibit binding of AL-5-FITC. AL-5-FITC presented a positive pattern identical to that obtained by conventional immunohistochemistry. As expected, unconjugated AL-5 inhibited binding of FITC-conjugated AL-5. Unfortunately, AL-l-FITC did not bind to the tissue sections, even under control conditions.
DISCUSSION
In previous studies we found that when embryonic lung explants were cultured in the presence of polyclonal antibodies to laminin, branching morphogenesis was inhibited and gross abnormalities occurred (Schuger et al., 1990) . Like other extracellular matrix glycoproteins, laminin is a multidomain macromolecule and its diverse biological activities are mediated by different segments of the protein in a way that seems to be cell-type or function specific. In order to determine whether the involvement of laminin in branching morphogenesis could be further localized to a particular domain, embryonic lung explants were cultured in the presence of monoclonal antibodies to various domains of the laminin molecule and their effect on morphogenesis was determined. The laminin domains to which each of the antibodies used in the present study localize have been established in previous reports by electron microscopy, and the laminin chains to which each antibody reacts have been determined by immunoblotting and radioimmunoassay (Skubitz et al., 1987 . All of the domains recognized by the antibodies have been reported to promote cell attachment (Terranova et al, 1983; Graf et al., 1987; Aumailley et ah, 1987; Skubitz et al., 1987; Charonis et al., 1988; Kouzi-Koliakos et ah, 1989; Kleinman et aZ., 1989; Tashiro et al., 1989) . In addition, some of these domains have heparin binding activity (Skubitz et ab, 1988) . In the present study monoclonal antibodies were used first to determine laminin distribution in the 12th day embryonic lung and second to evaluate the functional involvement of different laminin domains in lung morphogenesis. The immunohistochemical studies localized laminin predominantly to the basement membrane. However, some immunoreactivity was also diffusely present in the extracellular matrix. Since it is unlikely that laminin produced by epithelial cells extends beyond the basement membrane into the mesenchymal extracellular matrix, our findings suggest that laminin is expressed by both the epithelial and the mesenchymal cells. These findings coincide with previous studies conducted on other developmental systems, in which a dual tissue origin of laminin was demonstrated (Simon-Assmann et al., 1988) . The fact that not all of the monoclonal antibodies reacted with the laminin diffusely present in the extracellular matrix might indicate the existence of molecular isoforms differing structurally from each other. Alternatively, the lack of diffuse extracellular matrix staining with certain monoclonal antibodies may be due to masking of the appropriate epitopes.
Blocking experiments to determine the functional involvement of laminin in lung morphogenesis showed that two of the five antibodies interfered with organogenesis: antibody AL-l, which binds at the cross region of laminin, and antibody AL-5, which recognizes the globular segments of the B chain(s) (Skubitz et aZ,, 1987 (Skubitz et aZ,, , 1988 . Both antibodies inhibited branching morphogenesis in a concentration-dependent manner and this effect was abrogated by preincubation with laminin. Lung explants exposed to AL-5 presented severe alterations in the pattern of branching. These kind of alterations were uncommon in those explants exposed to AL-l, suggesting that the two antibodies may be blocking different laminin functions. There was no evidence of cytotoxicity with either AL-l or AL-5. However, explants exposed to both antibodies were smaller than controls and presented a decrease in the total number of mitotic figures . Interestingly, the inhibition in mitotic activity appeared to be specific for epithelial cells. There was no inhibition in the mesenchymal compartment. In fact, mitotic figures were prominent among mesenchymal cells. These observations suggest a complex effect of the antibodies on lung organogenesis rather than a general antiproliferative activity. Failure of the other three monoclonal antibodies to interfere with branching morphogenesis was not due to inability to penetrate the lung tissue in organ culture, since immunolocalization studies demonstrated that during culture all five antibodies penetrated the lung and bound to the basement membrane or, in the case of AL-5, reacted with cells close to the basement membrane.
It should be noted that the binding sites of antibodies AL-2 and AL-3, which did not affect branching, present partial overlap with the binding site of AL-l, which inhibited branching activity. The difference in effect may indicate that among these antibodies, the effective one is that which is able to bind at high concentration to a relatively small key segment in the molecule. Even more, blocking of critical amino acid sequences might be required to obtain an effect. Studies using synthetic peptides representing sequences from critical laminin sites will help to answer this question.
The current studies indicate that specific determinants of laminin appear to be required in order for the laminin molecule to be functionally active during lung morphogenesis. In previous studies using polyclonal antibodies to laminin, we could not rule out the possibility that inhibition of morphogenesis was caused merely by steric hindrance of the polyclonal antibody bound to the basement membrane. However, in this study using monoclonal antibodies we can ensure that only specific domains of laminin are blocked by each of the antibodies. Based on our results, we can suggest the following scenario to account for this inhibition of branching morphogenesis with monoclonal antibodies. Laminin synthesized by epithelial cells and probably also by mesenchymal cells becomes organized into a basement membrane. Epithelial cell receptors for laminin recognize segments at the cross-shaped part of the molecule or in the globular region of the short arms. The cells bind to these parts of laminin and carry out the func-DEVELOPMENTALBIOLOGY VOLUME 146,1991 ^\ c tions needed for normal morphogenesis.
Alternatively, inhibition of normal morphogenesis might not be the result of blocking laminin functions in the basement membrane but rather of the blocking of laminin diffusely present in the extracellular matrix. In such case, it may be the mesenchymal cell interaction with laminin that is affected. While this is speculative, the finding that the two antibodies that inhibited morphogenesis showed diffuse extracellular matrix reactivity supports such a possibility.
With regard to AL-5 specifically, this antibody presented a staining pattern that was distinct from the other antibodies. This antibody stained the mesenchyma1 compartment but failed to stain the basement membrane. On this basis, it could be suggested that AL-5 reactivity was due to interaction with molecules other than laminin however this is unlikely. Rotary shadow electron microscopy studies clearly demonstrated that AL-5 binds to a specific laminin region. This region, which is located at the terminal part of the lateral arms, has both cell binding and heparin binding activity (Skubitz, 1987 Kouzi-Koliakos, 1989) . AL-5 inhibits both heparin binding to laminin and cell adhesion to laminin (Skubitz, 1987 Kouzi-Koliakos, 1989) . It is evident from this that AL-5 recognizes epitopes on the laminin molecule and interferes with functions that are dependent on the same region of the molecule in which the epitopes reside. It should be pointed out that mesenchymal cells isolated from E-day mouse embryo lungs synthesize laminin in primary culture (manuscript in preparation).
Therefore, it would not be unreasonable to see staining of the mesenchymal compartment. Further while the lack of basement membrane staining with AL-5 is curious, it may be possible that the epitope for this antibody is either masked or not present in sufficient quantity to elicit a response with this antibody. (If the antibody were recognizing something in addition to laminin, this would not explain its lack of staining of the basement membrane.) Interestingly, it appears that the lack of basement membrane staining with AL-5 is developmentally regulated. When lungs form 14-day embryos are stained with this antibody, there is basement membrane staining as well as staining of the mesenchymal compartment (manuscript in preparation). Most importantly, incubation of soluble laminin with AL-5 completely abrogated its ability to interfere with normal mouse lung development. This is identical to what we saw when soluble laminin was incubated with AL-l, the other antibody which interferes with lung development. If a moiety other than laminin were responsible for reactivity with this antibody, soluble laminin would not be expected to compete. Taken together, these data strongly suggest that laminin is the antigen for AL-5 and that the unusual staining pattern seen in the 12-day mouse embryo lungs cannot be explained on the basis of failure to react with laminin.
How specific domains of laminin act to promote branching morphogenesis and how antibodies interfere with their biological activity are important questions that remain to be elucidated. Many possibilities should be considered. In recent years it has become clear that cell attachment, proliferation, migration, and polarization (all essential to normal morphogenesis) result from cell interactions with specific laminin domains. It is, therefore, possible that the two laminin domains defined in this study mediate one or more of the above functions. It is even possible that each of these domains serves a different function during lung development and that blocking of morphogenesis is an end result of interfering with one of several diverse biological processes. The ability of several laminin domains to promote cell attachment in a cell-type-dependent manner has been extensively documented.
Both the cross region of laminin and the globular domains of the B chain(s) have been reported to promote the attachment of a variety of cells. (Terranova et oh, 1983; Graf ef uh, 1987; , Kouzi-Koliakos et al., 1989 Kleinman et oh, 1989; Tashiro et al., 1989) . Proliferation of epithelial and mesenchymal cells, the two main cell populations of the embryonic lung, is an anchorage-dependent phenomenon. If the two laminin domains defined in this study promote the attachment of embryonic lung cells, then cell proliferation and consequentially branching morphogenesis could be facilitated by these domains. It follows that interfering with the functions of these critical domains could lead to an inhibition of branching morphogenesis. Conversely, if the binding of laminin to other basement membrane constituents such as proteoglycans or even laminin itself (Timpl, 1989 ) is perturbed, then a proper assembly of the basement membrane may not take place. This could also result in impaired morphogenesis. It should be noted in this regard that the domain of laminin that recognized antibody AL-5 has heparin binding activity and sequences of amino acids from this domain have been found to promote both cell adhesion and heparin binding (Charonis et ab, 1988; Kouzi-Koliakos et al., 1989) . Not all of the domains with cell and/or heparin binding activity appear to be involved in branching morphogenesis. The YIGSR-containing sequence, located near the intersection of the cross on the Bl chain of laminin (i.e., the domain recognized by antibody AL-3), promotes the attachment of numerous cell lines (Graf et al., 1987; Iwamoto et al, 1988) , whereas the globular end of the long arm, another established cell binding domain (Aumailley et ab, 1987; Goodman et al., 198'7) , is recognized by AL-4. However, antibodies against these domains did not affect morphogenesis. It can be suggested that although laminin contains multiple cell adhesionpromoting domains, not all of them play a role in branching morphogenesis at this stage of lung development.
In addition to facilitating adhesion, laminin is also known to have direct mitogenic activity for some cells. This effect has been localized to the inner segments of the short arms, close to the cross intersection in regions that are rich in epidermal growth factor-like repeats in their amino acid sequence (Panayotou et al., 1989) . The lack of inhibitory effect on branching development with antibody AL-3 (which binds to this region) seems to indicate that the effect of laminin on lung morphogenesis is not related to epidermal growth factor-like activity. Likewise, the long arm of the laminin molecule has been reported to play a role in the induction of polarization of tubular epithelium during embryonic kidney development (Klein et al, 1988) . Antibody AL-Z, directed against this region, did not alter epithelial polarization of the newly formed airways. The lack of effect with this antibody might indicate that cell polarization in the lung involves different mechanisms than those acting in the kidney. The process of conversion of mesenchyme into an epithelium, as occurs in the kidney, is quite different from the same process in the lung, in which a fully polarized epithelium proliferates and branches. In conclusion, two regions of the laminin molecule (i.e., the cross section and the globular regions of the lateral short arms) play a role in lung branching morphogenesis. Both domains regulate epithelium and mesenchyme growth and branching morphogenesis. This study was supported in part by a grant from the Tobacco Research Council (L.S.) and by Grant 1891179 from the Juvenile Diabetes Foundation (A.P.N.S.).
